IMRIS receives FDA clearance for IMRISNV and I... ( WINNIPEG Sept. 8 / IMRIS Inc. (TSX: I...)

IMRIS receives FDA clearance for IMRISNV and IMRIScardio

Date:9/8/2009

WINNIPEG, Sept. 8 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA), permitting the Company to market its newest products, IMRISNV and IMRIScardio in the United States.

IMRISNV and IMRIScardio are the first systems in the world to allow the capabilities of both MRI and x-ray angiography in a single suite without the need to transport the patient between modalities.

Neurovascular diseases including acute ischemic stroke require rapid assessment and treatment. IMRISNV features a wide bore 3T MRI scanner and a bi-plane angiography system completely integrated into a single suite that permits the patient to transition quickly and seamlessly between MR imaging and intervention without transporting the patient between modalities. Using IMRISNV, MR images can be taken before and during procedures to assess tissue health, and can also be used in conjunction with the fluoroscopic images during the interventional procedure. On completion of the procedure, new images can be taken to evaluate the intervention.

Cardiovascular interventions demand a high level of accuracy in the diagnosis of patients and in the assessment of treatments. IMRIScardio provides physicians with enhanced images for visualizing the cardiovascular system before, during and after an intervention. The IMRIScardio suite includes a wide bore 1.5T MRI scanner and a single-plane or bi-plane angiography system providing the ability to alternate between imaging modalities and immediately assess treatment.

IMRISNV and IMRIScardio are available in multiple room configurations to provide diagnostic, interventional and surgical capabilities, which significantly enhance the utilization of equipment and space for hospitals.

"The addition of IMRISNV and IMRIScardio expands our product portfolio and the scope of our market opportunity considerably," sa
'/>"/>

SOURCE IMRIS Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. IMRIS receives CE Mark approval for interventional imaging system
2. Huashan Hospital to install Asias first 3T IMRIS system for neurosurgery
3. IMRIS announces development program for MR guided radiation and interventional applications
4. IMRIS announces first IMRISneuro project in Australia
5. IMRISneuro: The iMRI technology of choice among the worlds top ranked hospitals
6. IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
7. Dell Childrens Medical Center to install IMRISneuro in expanded neurocenter
8. Senior GE Executive to lead IMRIS Sales team in the U.S.
9. University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
10. Providence St. Vincent bringing IMRISneuro, the worlds most advanced surgical MRI to Portland, Oregon
11. Conseco Receives Approval to Complete Reinsurance Transaction with Wilton Re

Post Your Comments:

(Date:11/20/2009)...ewswire-USNewswire/ -- The American Dental Associa...nistration (FDA) to establish appropriate classifi...ng concern about the safety of whitening products ... professional consultation or examination by a den... chemically based tooth whitening or bleaching age...

(Date:11/20/2009)... November 20 Cardio Vasc...VSLMEDICAL.COM , a leading,developer of advanced c...that,the company,s Board of Directors has decided ...and the Far East for its proprietary next-generati...lasty (PCTA) procedures. , Cardio Vascula...

(Date:11/20/2009)...Newswire-USNewswire/ -- The following is a stateme...ada Health Care Association: ,, "The Nevada Hea...nate Majority Leader Harry Reid for his leadership...l of protecting every Nevada seniors, ongoing acce...e strength and viability of our state,s vital fron...

(Date:11/20/2009)...November 20 in the Journal of the National Cancer...pes that often appear in news coverage of cancer r...the media and journals to help alleviate the probl...oloshin, M.D., M.S., of Center for Medicine and th...cy and Clinical Practice in New Hampshire, and Bar...

(Date:11/20/2009)...n children with chronic kidney disease often fail ...e visits increasing a child,s risk for serious he...kins Children,s Center and other institutions. A r...l of American Society of Nephrology. , Researc... during regular doctor visits to readings obtained...

Breaking Medicine News(10 mins):Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2 Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2 Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2 Health News:High blood pressure easy to miss in children with kidney disease 2

[0] American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products [0] Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East [0] Nevada Health Care Association (NHCA) Supports Majority Leader Reid [0] Promoting healthy skepticism in the news: Helping journalists get it right [0] High blood pressure easy to miss in children with kidney disease

...m Strong International Performance and InLight ..., Ill., Jan. 31 Landauer, Inc. (NYSE:,LDR), a rec...tion,monitoring, today reported record performance...ternational revenues in several regions and sa...

... Boomers feel young, but often ignore important, ...enise Austin to launch n...rs are living,longer and leading more active lives...NYSE: ENR ), nearly two-thirds,(64 percent) of ba...

...The Procter &,Gamble Company (NYSE: PG ) announce...n for the quarter. Sales were up behind strong vol...nitiatives and double-digit organic,growth in deve...ercent to $0.98 per share, above the top end of th...

...s through Long Term Healthcare Education, KIRKLAN...ienced employees are the ones companies want to ke...wn accord. Or they may start taking,time off. Why?...ness Development for LTC Financial Partners, the n...

...rthritis (RA), an inflammatory autoimmune disease,...lar disease (CVD). One explanation for this incre...tes atherosclerosis. A marker of inflammation, el...hns, for exampledo not carry the same high risk of...

...to dangerous levels in body and cause autism, new ...HealthDay News) -- The latest chapter in the debat... was written Wednesday with release of a study tha...himerosal has been used for decades, but the surge...

Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results Boomers: Feeling Young or Fooling Themselves?P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company Protecting Productivity at the Worksite in Challenging Times The HLA-DRB1 gene and premature death in rheumatoid arthritis Mercury in Childhood Vaccines Excreted Quickly

(Date:11/19/2009)... , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-Fi...: BCRX ) today announced the pricing of a public ...t $9.75 per share, resulting in gross proceeds of ...ed by BioCryst pursuant to an effective shelf regi...ities and Exchange Commission. BioCryst has also ...

(Date:11/19/2009)... , TAINAN, Taiwan, Nov. 19 /PRNewswire-...active pharmaceutical ingredients (APIs), announce... Compound Safety Certification from,SafeBridge(R) ...Pharm,s,competency and proficiency in the safe han...(APIs), and applies to specific laboratories and,p...

(Date:11/19/2009)... , ABBOTT PARK, Ill., Nov. 19 /PRNewswire-Fi...tt (NYSE: ABT ) as one of its Most Admired Corpo... The Deal honored Abbott as its Most Admired Deal...ategic use of acquisitions and divestitures since ...as reshaped its business portfolio with a focus on...

Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2 BioCryst Announces Pricing of Public Offering of Common Stock 3 ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2 The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2 The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3 Women with cystic fibrosis can have safe and successful fertility treatment 50402 1 Women with cystic fibrosis can have safe and successful fertility treatment 50402 2 Women with cystic fibrosis can have safe and successful fertility treatment 50402 3 The European Association for the Study of the Liver renews publishing partnership with Elsevier 50397 1 Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 1 Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 2 Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 3

[0] BioCryst Announces Pricing of Public Offering of Common Stock [0] ScinoPharm Announces SafeBridge Potent Compound Safety Certification [0] The Deal Names Abbott Top Dealmaker for Second Consecutive Year

...overage Changes Affect Region with Higher Incidenc...ates, SAN DIEGO, Aug. 7 CardioDynamics (Nasdaq:,...ce cardiography (ICG),technology, today announced ...and Medicaid Services (CMS) recently made changes ...overage of ICG for patients with,high blood pressu...

...ntinuing Progress on Clinical and Preclinical Prog...Inc. (Amex: KAL; FWB: CA4), a developer of new dru...ointestinal diseases, is pleased to provide an,upd...tivities for the,second quarter of 2007. "Callist...and,preclinical programs in 2007," stated Gary S. ...

Other Medicine Technology:Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 2 Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 3 Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 4 Callisto Reports on Second-Quarter 2007 Milestones 2 Callisto Reports on Second-Quarter 2007 Milestones 3 Callisto Reports on Second-Quarter 2007 Milestones 4

Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology Callisto Reports on Second-Quarter 2007 Milestones

...act is the first magnetic stimulator to offer the ... stimulation. It is designed to provide the simple...tic routine (at the same time, it may also help re...ons without moving away from your patient). , ,...

X-SIZER Catheter System

...g Power, Deeper Lesions ,Designed for the tr...lutter, Freezor MAX is a powerful ablation-only ca...n tip was designed to provide maximum cryo perform...he other cryocatheters, but its larger shaft and a...

... system is GEs premier digital cardiovascular syst...ocardiography, and a new dimension of comfort and ...g to customer input, using Six Sigma practices, GE...iovascular system that delivers what customers wan...

Medicine Products:

MagPro Compact X-SIZER Catheter System Freezor MAX Vivid 7

IMRIS receives FDA clearance for IMRISNV and I...( WINNIPEG Sept. 8 / IMRIS Inc. (TSX: I...),Health